Other languages Sansure Biotech Inc.

Equities

688289

CNE1000043J1

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-30 pm EDT			5-day change	1st Jan Change
20.15 ^CNY	+2.08%		+2.81%	+3.07%

Apr. 26	Sansure Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Feb. 29	Sansure Biotech's 2023 Profit Drops 81% as Revenue Slumps 84%	MT

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Sansure Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 26
Sansure Biotech's 2023 Profit Drops 81% as Revenue Slumps 84%	Feb. 29
Sansure Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28
ASEP Medical Holdings Signs JV Agreement with Chinese Medical Diagnostics Co Sansure Biotech Inc.	Nov. 22
Sansure Biotech Secures EU Certification For In Vitro Diagnostic Device	Nov. 15
Sansure Biotech Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30
Tranche Update on Sansure Biotech Inc.'s Equity Buyback Plan announced on October 21, 2022.	23-10-10
Sansure Biotech Inc.'s Equity Buyback announced on October 21, 2022, has closed with 9,865,793 shares, representing 1.7% for CNY 200 million.	23-10-08
Sansure Biotech Gets EU CE certification for 60 products	23-09-22
Certain A Shares of Sansure Biotech Inc. are subject to a Lock-Up Agreement Ending on 28-AUG-2023.	23-08-27
Sansure Biotech Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-16
Sansure Biotech's Human Papillomavirus Kit Gets EU Registration Certificate	23-07-27
Tranche Update on Sansure Biotech Inc.'s Equity Buyback Plan announced on October 21, 2022.	23-06-30
Sansure Biotech Inc.(SHSE:688289) dropped from Shanghai Stock Exchange Health Care Sector Index	23-06-09
Sansure Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25
Tranche Update on Sansure Biotech Inc.'s Equity Buyback Plan announced on October 21, 2022.	23-04-04
Sansure Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27
Asep Inc. Lower After Signing JV Term Sheet with Leading Chinese Medical Diagnostic Co. Sansure Biotech Inc.	23-01-30
Sansure Biotech Gets Certification for COVID-19 Kit	23-01-30
ASEP Medical Holdings Inc. Signs Joint Venture Term Sheet with Sansure Biotech Inc. in Preparation for the Commercialization of the Sepset(ER) Sepsis Diagnostic Test in China	23-01-27

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Sansure Biotech Inc.

Equities

688289

CNE1000043J1

Other languages

Filters